Newsroom
Sorted by: Latest
-
LHX Investors Have Opportunity to Join L3Harris Technologies, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)--LHX Investors Have Opportunity to Join L3Harris Technologies, Inc. Fraud Investigation with SBS Law...
-
CLMT Investors Have Opportunity to Join Calumet, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)--CLMT Investors Have Opportunity to Join Calumet, Inc. Fraud Investigation with SBS Law...
-
Novo recorde de leilão é estabelecido com a venda de falcão por AED 1,5 milhão na ADIHEX 2026
ABU DHABI, Emirados Árabes Unidos--(BUSINESS WIRE)--Sob o patrocínio de Sua Alteza Sheikh Hamdan bin Zayed Al Nahyan, Representante do Governante na Região de Al Dhafra e Presidente do Clube de Falcoeiros dos Emirados, o quinto leilão realizado como parte da 23ª edição da Exposição Internacional de Caça e Hipismo de Abu Dhabi (ADIHEX) 2026 atraiu um público notável, culminando na venda de um falcão Qarmousha Pure Ultra White por AED 1,5 milhão (USD 408.000). A venda representa o preço mais alto...
-
Sygnia Reveals New Activity by China-Nexus Threat Actor Fire Ant Targeting Trusted Infrastructure
SINGAPORE & TEL-AVIV, Israel & NEW YORK--(BUSINESS WIRE)--Sygnia, the foremost global cyber readiness and response team, released the findings of their investigation into ongoing activity by a China-nexus threat actor, targeting key infrastructure that routes, authenticates, connects, and manages high-value environments. Tracked by Sygnia as ‘Fire Ant’, the adversary leveraged novel attack tools and methods to target Cisco IOS XR routers and turn them into operational platforms that suppress ev...
-
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with severe hypertriglyceridemia (sHTG) during a Hot Line Late-Breaking Science session at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. SHASTA-3 and SHASTA-4 met their primary and all prespecified secondary endpoints and demonstrated deep and durable reductions in triglycerides (TG),...
-
L3Harris Celebrates Successful Launch of NASA’s Nancy Grace Roman Space Telescope
CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has contributed key elements to NASA’s successfully launched Nancy Grace Roman Space Telescope, an observatory designed to map the universe. The milestone also marks the culmination of more than a decade of engineering, innovation and collaboration between L3Harris and NASA’s Goddard Space Flight Center. L3Harris provided the 2.4-meter Optical Telescope Assembly (OTA) for NASA, which serves as Roman’s eye. The company also...
-
Angel Armor Launches the RISE® Plate Carrier, Expanding Coverage Without Sacrificing Mobility
FORT COLLINS, Colo.--(BUSINESS WIRE)--Angel Armor launches the RISE® Plate Carrier, a purpose-built tactical armor platform designed for SWAT teams, tactical law enforcement personnel and high-risk response environments. The new carrier officially debuts at the NTOA Conference in Booth 515, where it will be a primary product focus for Angel Armor throughout the show.The RISE® Plate Carrier was developed around a challenge tactical operators have faced for years: getting the coverage they need wi...
-
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data ex...
-
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital, that evaluated the investigational positron emission tomography (PET) radiotracer iodine 124 evuzamitide (I 124 evuzamitide) for the diagnosis of cardiac amyloidosis.1 The pivotal study met its primary endpoints in the assessment of sensitivity and specificity for the diagnosis of cardiac amyloidosis b...
-
一只猎鹰在2026年ADIHEX拍卖会上以150万迪拉姆成交,创下新的拍卖纪录
阿联酋阿布扎比--(BUSINESS WIRE)--(美国商业资讯)-- 在阿尔扎夫拉地区统治者代表、阿联酋猎鹰俱乐部主席Sheikh Hamdan bin Zayed Al Nahyan殿下的赞助下,2026年第23届阿布扎比国际狩猎与马术展(ADIHEX)期间举办的第五届拍卖会吸引了大量参与者,最终一只Qarmousha纯种超白猎鹰以150万迪拉姆(约合40.8万美元)成交。该成交价为本届展会所有拍卖会中的最高纪录。 这是该展会历史上规模最大的拍卖会的一部分,展会以“荣耀传承”(A Legacy of Pride)为主题,由Modon旗下公司ADNEC Group与阿联酋猎鹰俱乐部进行战略合作,在阿布扎比ADNEC中心举办。展会将持续至9月6日。 这只猎鹰由美国Mark Moglich猎鹰农场所有,以其稀有的纯白羽色和出众的体态特征脱颖而出。这只Qarmousha纯种超白猎鹰重达1000克,身长和翼展均为16.5英寸,吸引了众多顶级猎鹰师和竞拍者的关注。 ADNEC Group集团首席执行官Humaid Matar Al Dhaheri表示:“参与这些拍卖会的猎鹰品质卓越,充分体现...